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AbstrACt
Objective To systematically review the literature relating 
to the impact of multiple co-occurring modiiable risk 
factors for cognitive decline and dementia.
Design A systematic review and meta-analysis of the 
literature relating to the impact of co-occurring key risk 
factors for incident cognitive decline and dementia. All 
abstracts and full text were screened independently by 
two reviewers and each article assessed for bias using 
a standard checklist. A ixed effects meta-analysis was 
undertaken.
Data sources Databases Medline, Embase and PsycINFO 
were searched from 1999 to 2017.
Eligibility criteria For inclusion articles were required to 
report longitudinal data from participants free of cognitive 
decline at baseline, with formal assessment of cognitive 
function or dementia during follow-up, and an aim to 
examine the impact of additive or clustered comorbid risk 
factor burden in with two or more core modiiable risk 
factors.
results Seventy-nine full-text articles were examined. 
Twenty-two articles (18 studies) were included reporting 
data on >40 000 participants. Included studies consistently 
reported an increased risk associated with greater 
numbers of intraindividual risk factors or unhealthy 
behaviours and the opposite for healthy or protective 
behaviours. A meta-analysis of studies with dementia 
outcomes resulted in a pooled relative risk for dementia of 
1.20 (95% CI 1.04 to 1.39) for one risk factor, 1.65 (95% 
CI 1.40 to 1.94) for two and 2.21 (95% CI 1.78 to 2.73) 
for three or more, relative to no risk factors. Limitations 
include dependence on published results and variations in 
study outcome, cognitive assessment, length of follow-up 
and deinition of risk factor exposure.
Conclusions The strength of the reported associations, 
the consistency across studies and the suggestion of a 
dose response supports a need to keep modiiable risk 
factor exposure to a minimum and to avoid exposure to 
additional modiiable risks. Further research is needed to 
establish whether particular combinations of risk factors 
confer greater risk than others.
PrOsPErO registration number 42016052914.
bACkgrOunD   
Modifiable risk factors for cognitive decline 
and dementia are now well established 
and several are similar to those for cancer 
and cardiovascular disease.1 2 In particular, 
these include smoking, low physical activity, 
sedentary lifestyle, poor diet, excess alcohol 
consumption, midlife obesity, high blood 
pressure, midlife high cholesterol and 
diabetes. Depression, low social engagement 
and low cognitive engagement have also been 
linked to risk of late-life dementia.1 2 
To date, the literature linking such risk 
factors to incident cognitive decline and 
dementia has typically focused on the rela-
tionship between an individual risk factor 
and later cognitive outcome. Despite this, 
we know that the clustering or co-occurring 
of risk factors is the more likely scenario.3–5 
Population observed risk factor clusters typi-
cally include smoking, excess alcohol intake, 
poor diet and low levels of exercise.3–5 
However, although the best evidence for 
reduction in risk of cognitive decline comes 
from multifactorial clinical trials targeting 
multiple risk factors,6 there remains a 
lack of knowledge relating to the impact 
of risk factor burden and its composition. 
Targeting of effective public health risk 
strengths and limitations of this study
 Ź This is the irst systematic robust evaluation of the 
evidence relating to impact of co-occurring modii-
able risk factors for incident dementia and cognitive 
decline.
 Ź Strengths of this review include use of Cochrane-
based methodology with a robust search strategy, 
detailed search terms and successful coverage of 
the data resulting in representation of study popula-
tions from 18 studies and 9 countries across Europe, 
Australia and North America with >40 000 partici-
pants and follow-up from midlife and late life.
 Ź Limitations include a lack of representation from 
other parts of the world and a restricted opportunity 
for evidence synthesis due to variability in reporting 
of individual study results.
 Ź Data were able to be combined for 5 of the 18 
studies.
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reduction strategies for cognitive decline and dementia 
first requires identification of the ‘at-risk’ population. 
This, in turn, requires an understanding of the impact 
of co-occurring modifiable risk factors and the role of 
risk factor combinations or clusters (commonly occur-
ring risk factor combinations) on incident dementia 
and cognitive decline.
Our objective is to systematically examine the litera-
ture addressing clustering or co-occurring modifiable 
risk factors for incident cognitive decline and dementia 
within individuals, and to estimate, using meta-analysis, 
the impact of exposure to one or more modifiable risk 
factors compared with absence of risk factors on the risk 
of future cognitive decline and dementia.
MEthODs
The databases Medline, Embase and PsycINFO were 
searched for articles published between January 1999 and 
March 2017 using the search terms (cluster* or cluster 
analysis or summative or score or scoring or scale or scales 
or measure or measurement or additive or cumulative) 
AND (dementia or Alzheimer* or cognitive or cognition 
disorders) AND risk factors, limited to Adults and English 
language publications. See online supplementary text 1 
for details. To maximise identification of eligible studies, 
online supplementary focused electronic searches were 
undertaken to include scoring-related terms and clus-
ter-related terms separately with risk factors, vascular risk 
factors and ‘vrf’. Reference lists of the included articles 
were also reviewed (online supplementary text 1).
Inclusion criteria
 Ź Longitudinal studies with an explicit aim to examine 
the impact of additive or clustered modifiable risk 
factor burden for combinations of multiple core 
modifiable dementia risk factors (hypertension or 
high blood pressure, hypercholesterolaemia or high 
cholesterol, diabetes, high body mass index, smoking, 
excess alcohol, low physical activity and poor diet).
 Ź Some evidence or clear implication that participants 
were free of cognitive decline or dementia at baseline 
assessment.
 Ź Use of formal assessment of cognitive function or 
dementia or clear implication that formal dementia 
diagnosis took place (eg, cognitive decline assessed 
using general screening or neuropsychological 
testing, dementia diagnosis using standard diagnostic 
tools).
 Ź Report of cognitive decline or dementia outcomes.
Exclusion criteria
 Ź Non-English publications (in the absence of resources 
for translation).
 Ź Studies based solely on medical records without 
systematic assessment of risk factors.
 Ź Since the modifiable risk factors for dementia are 
primarily thought to commence their influence from 
early adult to mid-adult life, publications relating to 
non-adult populations were excluded.
 Ź Publications with delirium as a primary end point 
and those including populations with cerebral auto-
somal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADISIL) were excluded. 
Delirium is associated with acute cognitive decline and 
CADISIL populations have particular risk factor char-
acteristics and are at high risk of subcortical dementia 
occurring in middle age or early old age.
 Ź Publications reporting results for metabolic syndrome 
as a unitary risk factor were excluded. Metabolic 
syndrome represents a single particular cluster of 
vascular risk factors (usually defined as a requirement 
for 3/5 from obesity, high blood pressure, high plasma 
glucose, high serum triglycerides, low high-density 
lipoprotein levels) and its impact has already been 
examined systematically.7 8
 Ź As we were seeking to examine the impact of modi-
fiable risk factors, we excluded studies that included 
non-modifiable risk factors as an integral part of their 
risk measure, that is, where we could not evaluate the 
impact of modifiable risk factor burden.
 Ź Finally, we excluded comments, letters, editorials, 
guidelines, consensus documents and conference 
proceedings.
Search strategies were co-designed by a qualified infor-
mation professional (AB) and the principal investigator 
(RP) who conducted the literature searches. Screening 
of abstracts, or titles where abstracts were unavailable, 
was performed independently by two reviewers (RP, JP) 
with each reviewer compiling a list of studies for potential 
inclusion. The two reviewers compared lists with differ-
ences being resolved by discussion. Full-text copies of the 
selected papers were obtained by the principal investi-
gator and assessed independently for inclusion by each 
reviewer. Reference lists of the selected manuscripts were 
screened to identify other potentially relevant published 
papers.
Data were extracted independently by each reviewer 
and included papers were independently assessed for 
quality by both reviewers. An overall agreed risk of bias 
judgement was arrived at by consensus. A formal quality 
scoring scheme was not used as these can have poor 
discriminant ability; however, each paper was assessed 
against the key factors adapted from the Critical Appraisal 
Skills Programme checklists for evaluating randomised 
controlled trials and cohort studies, respectively (http://
www. casp- uk. net/ casp- tools- checklists).
Data relating to the population reported in each study 
(number, age at baseline, % female at baseline), plus 
length of follow-up, risk factors included and where 
applicable, cut-off points used to define presence of risk 
factor, cognitive outcomes, methods of risk factor combi-
nation and analysis, covariates and reported results were 
extracted to a standard data extraction form. Where 
various versions of the results were available, the most 
conservative, most adjusted results were selected. Narrative 
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synthesis was applied to describe and summarise the 
results of the included studies. Where summary measures 
included OR, HR or relative risks (RR), data relating to 
impact of clustering, defined as specific co-occurring risk 
factors or number of co-occurring modifiable risk factors 
were combined using meta-analytic techniques. The I2 
measure was used to assess the percentage of variation 
across studies due to heterogeneity rather than chance. 
Where possible, publication bias was also examined using 
Egger’s test and visual inspection of funnel plots.
The protocol for this review is registered with PROS-
PERO: the International prospective register of system-
atic reviews CRD42016052914. Published data were used. 
Neither ethical approval nor consent for participation or 
publication was required.
Patient involvement
We acknowledge the importance of patient/carer/lay 
person involvement in research. Although patients/
service users/lay people were not involved directly in the 
design of this systematic review, the development of the 
research question was supported and informed by several 
discussions held by the first author with older adult 
patient, carer and lay person groups on the subject of 
modifiable risk factors for dementia. As this was a review 
of published literature, there are no direct study partic-
ipants and no opportunity to involve patients/carers or 
lay people in the development of outcome measures or 
in recruitment. We have thanked all participants of the 
contributing studies in the acknowledgements section 
and will be disseminating results to both lay and scientific 
audiences via presentations, publications and interna-
tional dementia organisations.
rEsults
The main systematic literature search resulted in 8916 
records for review. The two supplementary focused elec-
tronic searches yielded 970 and 2870 records (supple-
mentary text 1 shows all search strategies). A further 
10 references were identified from reference lists and 
expert recommendation. Abstract review resulted in 101 
records retained for full-text evaluation (figure 1). Seven-
ty-nine records were excluded: 8 because it was unclear 
whether the sample populations had been free of cogni-
tive decline at baseline,9–16 9 due to a lack of appropriate 
cognitive outcomes,17–25 49 due to a lack of appropriate 
risk factor data, combining modifiable and non-modifi-
able risk factors or where risk factor relationships were 
not evaluated.26–74 Eleven were not longitudinal75–85; one 
was a review article86 and one a commentary.87 Twenty-two 
articles relating to 18 cohort studies were included in the 
review.88–109 There were two studies with multiple publi-
cations: the Whitehall II study106 107 and the Washington 
Heights Ageing Project.89 94 97 The articles differed in 
inclusion of risk factors, outcomes and analysis methods 
and so all were reported in the narrative results. Six 
studies reported risk ratios for risk factor exposure and 
incident dementia or Alzheimer’s disease (AD) allowing 
meta-analyses.88 89 93 98 100 101
study characteristics
The included studies totalled over 40 000 individuals 
recruited from high-income countries: the USA,88–97 
Sweden,98–100 Finland,101 the Netherlands,102 103 Germany,104 
France,105 the UK,106 107 Australia108 and Korea109 (table 1). 
Study sample sizes ranged from 322102 to 8845.93 Two 
studies recruited only men88 98 and for five articles, >50% 
of the participants were male.95 102 103 106 107 There were 
no female-only studies. Study follow-up varied from 22 
months92 to over 20 years.88 90 93 96 101 Detailed compar-
ison of follow-up is difficult, as different articles provided 
the information in differing ways. However, a broad cate-
gorisation can be made into very short follow-up, esti-
mated at <5 years,92 109 short follow-up, estimated at >5–10 
years,89 94 95 99 100 104 106 108 moderate follow-up, estimated 
at >10–20 years91 97 98 102 103 105 107 and long follow-up, 
estimated at >20 years.88 90 93 96 101 There were 12 articles 
where baseline measures were taken in midlife (>40 and 
≤65 years)88 93 96 98 99 101–103 105–108 and 9 articles where the 
baseline was in late life (>65 years).89 91 92 94 95 97 100 104 109 
One study included those in earlier adult life with base-
line age ~26 years.90
Cognitive outcomes
Eight manuscripts reported on dementia outcomes using 
standard diagnostic criteria,88 89 95 97 98 100 101 1032 used a 
dementia diagnosis made as part of medical treatment but 
did not give details of diagnostic criteria,93 1045 reported 
results specifically for AD88 89 97 98 100 and 12 reported on 
non-dementia cognitive outcomes. Cognitive measures 
included use of a screening test92 109 or a neuropsycho-
logical battery.91 94 96 99 102 105–108 See table 2 for details of 
the diagnostic criteria and assessment tools used by each 
study.
risk factor measurement
Articles varied in their selection of risk factors and the risk 
factors varied in number (from 2 to 13) and definition. 
See table 1 and online supplementary table 1 for details of 
risk factors included in each study and the cutpoints used 
to define presence of risk factors. Substantial overlap was 
identified for coverage of risk factors between studies; the 
most commonly included risk factors being smoking and 
hypertension or high blood pressure, although no single 
risk factor was common to all studies (table 1).
Different analyses aggregated risk factors or unhealthy 
behaviours or protective factors or healthy behaviours in 
different ways (table 2). Three used some form of clus-
tering, cluster analysis, latent factors or principal compo-
nent analysis and examined the relationship between 
membership of each cluster and cognitive outcome,95 99 105 
15 studies categorised each risk factor as present or absent 
(1 or 0) and then generated a variable which was the total 
number of risk factors present.88–94 96 98 100 101 104 107–109 
Three elaborated further by creating a weighted risk 
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score97 102 103 and one used categories to combine two 
risk factors (alcohol and smoking) to examine additive 
impact.106
In general, studies used either linear, logistic or 
Cox proportional hazard regression (tables 2 and 3) 
to examine the relationship between baseline risk 
and cognitive outcomes; one study used latent growth 
curves106 and one provided graphical results only.96 Five 
studies looked at the inverse of risk factors and reported 
on protective or ideal health behaviours.90 91 97 104 109 
Most studies adjusted for age, sex and education and/
or socioeconomic status (tables 2 and 3); one adjusted 
for age and sex only102; one for sex only91; one for 
patterns of test completion and sex and in one case no 
information on the method of covariate adjustment was 
provided.96
Association between risk factors and cognitive outcomes and/
or dementia
Study findings showed remarkable similarity with the 
majority reporting a relationship between exposure to 
increased risk factor load and subsequent poorer cogni-
tive function or dementia (table 3). No clear differences 
of results were observed by baseline age group, that is, 
cohorts in midlife or late-life at baseline, or for length 
of follow-up, although the varied presentation of study 
results meant that formal statistical testing could not be 
performed.
Eleven articles reported a relationship between risk 
factors and cognitive outcomes88 89 92 93 96 98–103; three 
between unhealthy behaviours105–107 and poorer cogni-
tive outcomes; three reported a relationship between 
protective factors97 104 109 and two between ideal health 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses low chart detailing the number of records 
included at each stage of the review.
 o
n
 4 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022846 on 25 January 2019. Downloaded from 
5
P
eters R
, et al. B
M
J O
p
en
 2
0
1
9
;9
:e0
2
2
8
4
6
. d
oi:1
0
.1
1
3
6
/b
m
jop
en
-2
0
1
8
-0
2
2
8
4
6
O
p
e
n
 a
c
c
e
s
s
Table 1 Characteristics of 22 studies included in systematic review
Study name Population
Age at baseline
Mean (SD) unless 
otherwise stated
Young adult 
life, midlife 
or late-life 
baseline
Per cent 
female
Follow-up
Mean (SD) unless 
otherwise stated Risk factor data
Betula Study99 Sampled from the population registry in 
Umea, North Sweden. N=879 wave 1, 
n=756 wave 2, n=613 wave 3
Originally sampled 10 age 
cohorts of n=100, each 
5 years apart, cohort 1 
born in 1953–1954 cohort 
10 born in 1908–1909. 
Mean at wave 1 56.25 
(14.09) range 35–80
Midlife 52 Data collection every 
5 years from 1988. Data 
from waves 1–3 used. 
~10-year follow-up
Multiple factors measured for use 
in principal components analyses: 
total serum cholesterol, triglycerides, 
thyroxine, thyroid-stimulating hormone, 
B12, folate (B9), albumin, haemoglobin, 
erythrocyte sedimentation rate, 
glucose, haemoglobin A1c, resting 
systolic and diastolic blood pressure, 
body mass index (BMI).
Cache County Study 
95
Population-based community sample of 
older adults in Cache Country Utah, USA. 
n=2491
73.0 (5.7) Late-life 49 6.3 (5.3) years Smoking, alcohol intake, diet, physical 
activity, social interaction, church 
attendance.
Cardiovascular Risk 
Factors, Ageing and 
Dementia (CAIDE) 
study101
Random population-based sample. Data 
collection in midlife in 1972, 1977, 1982, 
1987. Those individuals still alive aged 
65–70 years at the end of 1997 and living 
in two geographically deined areas in or 
close to the towns of Kuopio and Joensuu, 
Finland were targeted for follow-up. A 
random sample of 2000 invited for re-
examination in 1998. Sample n=1449
Baseline 50.6 (6.0), 
follow-up 71.6 (4.1)
Midlife 62 21 (4.9) years Systolic and diastolic blood pressure 
(BP), BMI, total cholesterol.
Coronary Artery 
Risk Development in 
Young Adults 90
Black and white adults recruited from four 
US cities (in four states Alabama, Illinois, 
Minnesota, California). Population samples 
balanced within each centre for age (18–
24/25–30), sex, race and education. 44.8% 
black. n=2932
~26 Young adult life 55 25 years. Assessments of 
dietary intake at baseline, 
7, 20 years, BP, total 
cholesterol, glucose at 
baseline, 7, 25 years, 
cognitive function at 
25 years
Smoking, physical activity, total 
cholesterol, fasting glucose, BMI, diet, 
systolic and diastolic BP.
Framingham Study96 Population-based longitudinal study, USA. 
From the sample of 2123 administered 
the neuropsychological battery at exam 
14/15, 1974–1978, those without prior 
stroke, dementia, cardiovascular disease 
or event (includes myocardial infarction, 
angina pectoris, congestive heart failure, 
intermittent claudication, coronary 
insuficiency) were selected. Analytical 
sample n=1423
Women 67.2 (7.3), men 
55.7 (6.9), (range 55–88)
Midlife 61 ~30 years. Visits every 
2 years from 1948 until 
neuropsychological 
testing in 1974–1978
Obesity and hypertension assessed 
from 1954.
Honolulu Asia 
Ageing Study88
Japanese American men residing in 
Honolulu, Hawaii, in 1965. Sample n=3555
Baseline, mean 52.7 (4.5). 
Follow-up, mean 77.8 
(4.6)
Midlife 0 1965–1991–1993 
(~27 years)
Systolic and diastolic BP, BMI, random 
triglycerides, total cholesterol, post 
load glucose, subscapular skinfold 
thickness.
Continued
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 Study name Population
Age at baseline
Mean (SD) unless 
otherwise stated
Young adult 
life, midlife 
or late-life 
baseline
Per cent 
female
Follow-up
Mean (SD) unless 
otherwise stated Risk factor data
Hoorn Study102 General population study. The Netherlands. 
On glucose metabolism. n=322
55.9 (3.7), (range 50–75) Midlife 49 1989–2008 CAIDE dementia score; modiiable risk 
factors, systolic BP, BMI, cholesterol, 
physical activity.
Intervention project 
on cerebrovascular 
disease and 
dementia in 
the district of 
Ebersberg104
Population-based cohort study. Germany. 
n=3547
67.3 (7.6) Midlife 59 2001–2003–2008 Systolic and diastolic BP, smoking, 
BMI, physical activity, total cholesterol, 
fasting glucose.
Kaiser Permanente 
Medical Care 
Program93
Kaiser Permanente is a non-proit health 
delivery system with members that are 
representative of the local population. USA. 
n=8845
42. For those who 
remained without 
diagnosis of dementia: 
42.0 (1.4). For those 
who went on to gain a 
diagnosis of dementia: 
42.3 (1.4). Range 40–44
Midlife 54 Mean 26.7 years 1964–
1973–2003
Systolic and diastolic BP, diabetes, 
cholesterol, smoking.
Kungsholmen 
project100
Recruited those aged 75 years and over 
living in Kungsholmen in Stockholm, 
Sweden, in October 1987. Baseline 
n=1810, included in analyses n=1270
81.5 (5.0) Late-life 75 Mean 5.1 (maximum 10.5) 
years, visits in 1987/1999, 
1991/1993, 1994/1996 
and 1997/1998
Systolic and diastolic BP, pulse 
pressure, medical history and 
medication data from medical records.
Maastricht Ageing 
Study103
Population-based cohort study, The 
Netherlands. n=949
65.0 (8.7), >55 Midlife 49 12 years. From 1993 to 
1995
A weighted risk score ‘Lifestyle for 
Brain Health’ created using standard 
techniques and 11 risk factors: low/
moderate alcohol consumption, 
coronary heart disease, physical 
inactivity, renal dysfunction, diabetes, 
high cholesterol, smoking, obesity, 
hypertension, depression, high 
cognitive activity.
Personality And Total 
Health, Path through 
life study108
Longitudinal cohort study, Australia. 
Participants were recruited from the 
electoral role, n=2530
~42.6 (range 40–44) Midlife 53 8 years Diabetes, systolic BP, smoking, 
depression, physical activity, BMI.
San Luis Valley 
Health and Aging 
Study92
Population-based study of health and 
disability in the Hispanic and non-Hispanic 
white population, USA? n=1444 at 
baseline, n=787 with follow-up, without 
cognitive impairment (Mini-Mental State 
Examination (MMSE)≥24) and with 
cardiometabolic measures
Hispanic 71.0 (5.9), white 
72.7 (7.5)
Late-life Hispanic 
58, white 
60
22 months Diabetes, central obesity, hypertension.
Table 1 Continued 
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Study name Population
Age at baseline
Mean (SD) unless 
otherwise stated
Young adult 
life, midlife 
or late-life 
baseline
Per cent 
female
Follow-up
Mean (SD) unless 
otherwise stated Risk factor data
Supplementation en 
vitaminsvitamines 
et mineraux 
antioxydants 
study105
Participants from the Supplementation en 
vitamines et mineraux antioxydants trial, 
France, who consented to a post-trial 
observational follow-up study. The trial ran 
in 1994–2002 and recruited 12 741 healthy 
adults. Observational study follow-up took 
place in 2007–2009 in 6850. Sample used 
in these analyses n=2430
Follow-up 65.6 years (4.5) Midlife 45 13 (0.7) years Smoking, physical activity, alcohol 
intake, sedentary behaviour, BMI, 
vegetable intake, seafood intake.
Suwon Longitudinal 
Ageing Study109
Sample of community dwelling adults aged 
65 years and over, South Korea. Sample 
n=537 at year 3
73.0 (5.7) Late-life 61 3 years Smoking, physical activity, vegetable 
consumption, alcohol consumption, 
social activity.
The Northern 
Manhattan Study91
A subsample n=1091 aged>50 years with 
white, black or Hispanic ethnicity drawn 
from a population-based cohort identiied 
from random digit dialling and including 
those residing in Northern Manhattan, 
USA, for >3 months, with a telephone and 
with no prior stroke. n=722 with follow-up. 
n=638 with follow-up and without cognitive 
impairment at baseline
71.7 (8.4) at irst 
neuropsychological 
assessment
Late-life 61 ~12 years. From baseline 
1993/2001 to irst 
neuropsychological 
assessment 7.2 (2.4) 
years; from irst to second 
neuropsychological 
assessment 6 (2.0) years
Smoking, BMI, physical activity, diet, 
total cholesterol, systolic and diastolic 
BP, fasting plasma glucose.
Uppsala Longitudinal 
Study of Adult Men98
Population cohort, Sweden, all men born 
1920–1924 invited (aged 50 years), 2322 
participated at baseline, 1174 with no 
dementia included in follow-up
Baseline 49.6 (0.6), 
follow-up 71.0 (0.6)
Midlife 0 20 years Systolic BP, BMI, fasting plasma 
glucose, serum cholesterol, smoking 
status, education level, apolipoprotein 
ڙ4.
Washington Heights 
cohort89
Longitudinal cohort of Medicare 
recipients residing in Northern Manhattan 
(Washington Heights), USA. Sample 
n=1138
76.2 (SD 2.9) Late-life 70 1992–1994–2003. Mean 
5.5 (SD 3.2) years
Hypertension, heart disease, diabetes, 
smoking, high-density lipoprotein 
(HDL), low-density lipoprotein (LDL) 
cholesterol and triglycerides, BMI, 
smoking and homocysteine levels (the 
later excluded as data not available for 
the whole sample).
Washington Heights 
cohort97
Longitudinal cohort of Medicare 
recipients residing in Northern Manhattan 
(Washington Heights), USA. Sample 
n=1880
77.2 (SD 6.6) Late-life 69 1992–1994–2006 Physical activity, diet.
Washington Heights 
cohort94
Longitudinal cohort of Medicare 
recipients residing in Northern Manhattan 
(Washington Heights), USA. Sample 
n=4077
White 78.0 (7.4), black 
77.8 (7.1), Hispanic 76.6 
(6.7)
Late-life White 64, 
black 71, 
Hispanic 
69
Median 5, 41. From 1992 
to 1999 followed every 
18–30 months
Individual risk factors not explicitly 
stated in this publication but states 
that it was the same as the score used 
by Luchsinger et al.89 Hypertension, 
heart disease, diabetes, smoking. HDL, 
LDL cholesterol, triglycerides, BMI, 
smoking and homocysteine levels.
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behaviours90 91 and better cognitive outcomes at follow-up. 
For the remaining studies, that is, those that reported a 
more mixed relationship between risk factor exposure 
and increased risk, the Personality and Total Health 
study found that only reaction time showed a relationship 
between risk factors and cognitive outcomes108; for the 
Schneider et al analyses of the Washington Heights study, 
risk factors were only associated with a small attenuation 
in decline in memory measures in black participants94 
and in the Cache Country study, the unhealthy behaviours 
plus religious belief cluster showed an increased risk of 
dementia, while the unhealthy behaviour, non-religious 
group and the healthy behaviour groups did not.95 In addi-
tion to the Cache County study, two further studies exam-
ined the relationship between groups of co-occurring risk 
factors. The Supplementation en vitamines et mineraux 
antioxy dants study study reported that their unhealthy 
lifestyle latent factor was associated with poorer memory 
but not with executive function and that the main drivers 
for this association were low fruit and vegetable consump-
tion and low physical activity.105 The Betula Study found 
that varying clusters of health components (metabolic, 
glycaemic, lipid, thyroid, inflammatory and nutritional 
clusters) had varying relationships with differing cogni-
tive abilities with the metabolic component showing the 
strongest relationships99 (table 3).
Finally, results were essentially consistent across the 
studies with more than one publication. The Whitehall 
study found a relationship between increased risk factor 
exposure and different measures of cognitive decline 
using both latent growth curve106 and logistic regression 
analyses107; the Washington Heights study reported an 
increased risk of incident AD89 with greater numbers of 
risk factors and a lower risk of incident AD with greater 
health behaviours (diet and physical activity).97
Six studies provided various risk ratios for the impact 
of one, two or three or more risk factors; five for incident 
dementia88 93 98 100 101 (figure 2 and online supplementary 
text 2 show results of each meta-analysis) and three for 
AD (online supplementary figure 1).89 98 100 Forest plots 
of these showed a clear dose response such that higher 
numbers of risk factors were associated with an increased 
risk. Based on the rare disease assumption,110 RRs, ORs 
and HRs were combined in two separate meta-analyses, 
one for dementia and the other for AD, yielding pooled 
ratios for presence of one, two and three or more risk 
factors compared with no risk factors. A fixed effects 
meta-analysis was used because the number of studies 
was small preventing a good estimate of the between 
study variance, however for comparability results are 
also reported for a random effects model. See online 
supplementary text 2 for details of the meta-analyses. 
For dementia outcomes fixed effect pooled risk ratios for 
one risk factor were 1.2 (95% CI 1.0 to 1.4), for two risk 
factors 1.7 (95% CI 1.4 to 1.9) and for three or more risk 
factors 2.2 (95% CI 1.8 to 2.7).88 93 98 100 101 Results for the 
random effects model did not differ. Heterogeneity was 
low and there was no evidence of publication bias (online S
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Table 2 Outcomes and analysis methods for 22 studies included in systematic review
Study Cognitive outcomes Risk factor aggregation, classification of risk factor exposure measure Analysis methods
Betula Study 99 11 episodic recall tasks, 3 recognition 
tasks, 4 luency tasks (2 semantic, 2 
phonemic) and a spatial ability task
Component scores. Cognitive scores 
converted to z scores and combined for 
each cognitive domain
Six factors were obtained from the 14 health variables using principal components 
analyses. Metabolic component (systolic blood pressure (BP), diastolic BP and body mass 
index (BMI)
Glycaemic component (glucose, haemoglobin A1c)
Lipid component (triglycerides, total cholesterol)
Inlammatory component (erythrocyte sedimentation rate, haemoglobin, albumin)
Nutritional component (B12, folate)
Thyroid component (thyroid-stimulating hormone, thyroxine)
Residual change scores computed for health and cognitive change between waves 1 and 2 
and cognitive change between waves 1 and 3 and waves 2 and 3
Three sets of longitudinal analysis:
1. Health factors at baseline predicting cognitive change 
between waves 1 and 3.
2. Change in health factors between waves 1 and 2 
associated with cognitive change between waves 1 and 
2.
3. Change in health factors between waves 1 and 2 
predicting cognitive change between waves 2 and 3.
Cache County Study 95 Incident dementia
(Diagnostic Statistical Manual IIIR 
(DSMIIIR)) and Alzheimer’s disease (AD) 
(National Institute of Neurological and 
Communicative Disorders and Stroke 
and the Alzheimer’s Disease and Related 
Disorders Association (NINCDS-ADRDA))
Latent class analysis to identify patterns in the six lifestyle behaviours Relationship between latent classes and incident 
dementia examined by proportional hazards regression 
using years to dementia starting at age 65 years.
Four lifestyle classes were identiied.
Cardiovascular Risk 
Factors, Ageing and 
Dementia study101
Incident dementia (DSMIV) and AD 
(NINCDS-ADRDA)
Dichotomised then summed three midlife risk factors (from surveys in 72, 77, 82 and 87) Logistic regression comparing those with 1, 2 or 3 
risk factors with those with no risk factors for incident 
dementia at re-examination as the outcome. Were there 
>3?
Coronary Artery Risk 
Development in Young 
Adults90
Digit Symbol Substitution Test, Stroop test, 
Rey Auditory Verbal Learning Test (long 
delay free recall)
Seven health factors were categorised as ideal, intermediate or poor heath using a slightly 
modiied version of the American Heart Association (AHA) criteria (online supplement 
text 1). The total number of health components at ideal levels was calculated based on 
the average level of each across the 0, 7 and 25 year examinations as well as the number 
present at years 0 and 25. The score ranged from 0 (none at ideal levels) to 7 (all ideal). 
Also used a cut point of ≥5 ideal health metrics at 0, 1, 2 or all 3 examinations and a score 
of 1–14 where poor health scored 0, intermediate health 1 and ideal health 2 also based on 
average exposure
Multivariable linear regression was used to estimate 
the association between health components and each 
cognitive function.
Multiple imputation used to impute missing values 
using data from all eight examinations and resulting in 
complete year 0, 7 and 25 data for 2932 individuals. 
Additional sensitivity analysis performed on 1753 
participants who had complete information on all health 
behaviours and factors across all three examinations.
Framingham Study 96 Kaplan Albert neuropsychological 
battery—includes logical memory, visual 
reproduction, paired associates, digit span 
forwards and backwards, similarities, word 
luency, delayed memory
Score used as the independent variable, 0 for neither risk factor, 1 for each risk factor and 2 
for presence of both risk factors
Linear regression to examine the combined effect of 
obesity and hypertension on cognitive measures.
Honolulu Asia Ageing 
Study88
Incident dementia (DSMIIIR), AD (NINCDS-
ADRDA), vascular dementia (criteria 
provided by the California Alzheimer’s 
Disease and treatment centres)
Risk factor measures converted to z scores. Those with skewed distributions were 
transformed prior to conversion and the relationships with the outcome checked to ensure 
they were linear. Z scores were summed over the seven risk factors thus ensuring a 
contribution from each risk factor
Logistic regression used to evaluate the relationship 
between the z score sum and dementia outcome. 
Results are reported as relative risks (RR) under the 
rare disease assumption that OR can be considered an 
approximation of RR.
Hoorn Study102 Neuropsychological battery including 
memory, working memory, immediate 
memory, delayed memory, attention and 
executive function, processing speed, 
visuoconstruction, language and abstract 
reasoning test z scores
Z scores were adjusted on an individual 
basis for age, sex, IQ Impairment deined 
as z score≤1.5
Weighted risk score included additional weights for older age, lower education and sex. The 
four modiiable risks were scored as 0 or 1 and summed. See online supplementary table 1 
for details of cut points.
Logistic regression to evaluate risk of impairment. 
Reanalysed excluding non-modiiable risk factors from 
the score.
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Study Cognitive outcomes Risk factor aggregation, classification of risk factor exposure measure Analysis methods
Intervention project 
on cerebrovascular 
disease and dementia 
in the district of 
Ebersberg104
Dementia diagnoses retrieved from health 
insurance claims data, diagnosis was 
required to be recorded on at least two 
quarterly records
Six risk factors scored as ideal 2 points, moderate 1 point and poor 0 points Proportional hazard regression used to evaluate the 
relationship between baseline score and incident 
dementia. Time from baseline until date of diagnosis in 
the health insurance records.
Kaiser Permanente 
Medical Care 
Program93
Dementia diagnoses entered by treating 
physician. Dementia ascertainment from 
1994 to 2003
A composite cardiovascular risk score was created using midlife hypertension, diabetes, 
high cholesterol, smoking. Each risk factor scored 1 if present and summed to a maximum 
of 4
Proportional hazard regression used to examine the 
relationship between baseline risk factors and dementia 
outcomes.
Kungsholmen 
project100
Dementia assessment at each visit, DSMIII. 
Diagnoses: dementia and AD
Created vascular risk proiles by scoring vascular risk factors. Overall vascular risk proile 
included high systolic and low diastolic BP, low pulse pressure, diabetes or pre-diabetes, 
prior stroke and diagnosis of heart failure. Atherosclerotic risk proile included high systolic 
BP, diabetes or pre-diabetes and stroke; hypoperfusion risk proile included low diastolic 
BP, low pulse pressure and heart failure
Cox proportional hazard models used to examine 
various vascular proiles in association with risk of 
dementia and AD.
Maastricht Ageing 
Study103
Dementia diagnosis by consensus 
committee (neuropsychologist and 
neuropsychiatrist) based on DSMIV. 
Cognitive testing, verbal memory, executive 
function, processing speed. Incident 
cognitive impairment deined as <1.5 SD 
below the mean on any of the cognitive 
tests at 6-year or 12-year assessments
Risk score created by taking the natural logarithm of the RR for each risk factor, 
standardised by taking the result from the lowest natural log of the RRs as a reference value 
and dividing the other values by this value. Then summing the resulting scores assigned to 
each risk factor to create a risk score
Proportional hazard regression used to examine 
relationships between risk score and incident cognitive 
decline and dementia. Linear mixed models used to 
examine relationships between risk score and cognitive 
change.
Northern Manhattan 
Study91
Neuropsychological battery combined into 
z scores for episodic memory, processing 
speed, semantic memory and executive 
function (based on exploratory factor 
analysis of the full battery and prior work)
For change in cognitive score, composite 
scores in the four cognitive domains were 
calculated using regression-based reliable 
change indices of the corresponding 
individual test adjusted for age, education 
years and the time between the two tests
The seven health factors were categorised as ideal or not ideal based on the AHA 
deinitions and summed to reach a score between 0 and 7
Multivariable linear regression models used to examine 
the association between baseline health factor score 
and z scores at neuropsychological testing wave 1 
and change in z scores between neuropsychological 
testing between waves 1 and 2. Scores were examined 
continuously and divided into four categories: 0–1 
(reference), 2, 3, 4–7 health factors.
Personality and Total 
Health, Path through 
life study108
Neuropsychological battery including 
measures of verbal ability, processing 
speed, delayed and immediate recall, 
working memory and reaction time. A 
global score was calculated by summing 
standardised test scores for the six 
individual items and dividing by 6
A risk score (PATHrisk) was constructed from six individual risk factors (each risk factor 
contributed one point to a total of six)
Multivariable models were used to examine the 
relationship between baseline PATHrisk score and 
cognitive function across all three waves of the 
study. Two main models were used, the irst included 
gender, time, PATHrisk*time and PATHrisk. The second 
included gender, time, education, time*PATHrisk and 
education*PATHrisk. Individual risk factors were also 
examined.
San Luis Valley Health 
ad Aging Study 92
Incident cognitive decline deined as a 
fall in Mini-Mental State Examination 
(MMSE)≥2 points at follow-up. Incident 
executive dysfunction deined as a 
decline≥0.5 of SD (2.5–3 points) in the 
executive control behavioural dyscontrol 
scale
The three individual risk factors were dichotomised as present/absent and summed to 
create a score
Logistic regression was used to examine the relationship 
between risk factors and cognitive decline.
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Study Cognitive outcomes Risk factor aggregation, classification of risk factor exposure measure Analysis methods
Supplementation en 
vitamines et mineraux 
antioxydants study105
Several standard neuropsychological 
tests administered and two summary 
measures based on executive function and 
verbal memory plus an overall composite 
cognitive score derived
To identify latent unhealthy lifestyle factors related to cognition used structural equation 
models
Used analysis of covariance to estimate associations 
between individual and combined unhealthy behaviours 
(as categories and on a continuous scale). Also created 
and modelled a score of 7 dichotomised unhealthy 
variables.
Suwon Longitudinal 
Ageing Study109
Korean MMSE. Change over follow-up Dichotomised then summed positive four health behaviours to form a protective score Used multivariable linear regression to examine inluence 
of risk/protective factors on cognitive change.
Uppsala Longitudinal 
Study of Adult Men98
Expert panel review of medical records 
up to 1 January 2010. Dementia (DSMIV 
criteria), AD (NINCDS-ADRDA), vascular 
dementia (Alzheimer’s Disease Diagnosis 
and Treatment Centre, mixed dementia (AD 
and cerebrovascular contribution)
Five risk factors scored 1 if present (smoking) or above a deined cut-off for BMI, systolic 
BP, fasting plasma glucose, serum cholesterol, maximum score 5
Cox proportional hazard regression used to evaluate risk 
of dementia calculated for individual and summed risk 
factors present at age 50 and at age 70 years.
Washington Heights 
cohort89
Consensus conference to diagnose 
dementia. Diagnosis of AD based on 
NINCDS-ADRDA
Four risk factors were dichotomised and treated as time dependent covariates where 
follow-up date was date of diagnosis. Median and quartiles used for BMI and low-density 
lipoprotein (LDL) cholesterol. Retained variables were summed to create a score. Date of 
event was age of onset of dementia
Proportional hazards regression. Risk factors entered 
into univariate analyses, those achieving signiicance 
values of ≤0.1 were retained in multifactorial regression.
Washington Heights 
cohort97
Consensus conference to diagnose 
dementia based on DSMIIIR. Diagnosis of 
AD based on NINCDS-ADRDA
Diet score non-binary, range 0–9, higher is better, physical activity dichotomised into low 
and high. Risk evaluated for combinations of physical activity and diet score.
Proportional hazard regression time to AD (irst visit with 
AD diagnosis).
Washington Heights 
cohort94
A global composite, executive function 
composite and memory composite 
score from factor analysis of data from a 
neuropsychological battery
Four risk factors were dichotomised and treated as time-dependent covariates where 
follow-up date was date of diagnosis. Median and quartiles used for BMI and LDL 
cholesterol. Retained variables were summed to create a score. Date of event was age of 
onset of dementia
Multiple group parallel process random effects 
regression using data from all follow-up evaluations 
adjusted for retest effects.
Whitehall II study106 Global cognitive score combining z 
scores from tests of inductive reasoning, 
short-term verbal memory, verbal luency. 
Cognitive function assessed at baseline, in 
2002–2004 and 2007–2009
Examined association between smokers, never and ex-smokers, abstinent, moderate and 
heavy alcohol users and their interactions and global cognition score
Latent growth curve models (allowing correlation 
between repeated measures) to examine the association 
between smokers, never and ex-smokers, abstinent, 
moderate and heavy alcohol users and their interactions 
and global cognition score. Sensitivity analyses: 
analyses repeated for those with an MMSE≥24 in 2002–
2004 and 2007–2009.
Whitehall II study107 Memory an executive function. The 
latter derived from a composite of three 
neuropsychological tests. Memory was 
assessed using a verbal memory free recall 
test. Poor executive function deined as the 
lowest sex speciic quintile. Poor memory 
as <5/20 words correctly recalled
Summed (dichotomised) scores of 4 health behaviours at each phase and across all three 
phases
Univariate logistic regression relating individual health 
behaviours to cognitive outcomes at phase I, V and VII 
(cross-sectional) followed by summed (dichotomised) 
scores of health behaviours at each phase and across all 
three phases.
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Table 3 Results for 22 studies included in systematic review
Study Result Covariates adjusted for Risk factor handling
Betula Study99 1: Health factors at baseline predicted cognitive change between waves 1 and 3
Metabolic component predicted fall in performance on recall, recognition, spatial ability and phonemic luency (P<0.001 for all).
Glycaemic component predicted fall in performance on recall (P<0.001), recognition (P<0.01), spatial ability (P<0.01), phonemic luency 
(P<0.001).
Lipid component predicted fall in performance on recall (P<0.001), recognition (P<0.01), spatial ability (P<0.001), phonemic luency 
(P<0.001).
Thyroid component predicted fall in performance on recall (P<0.05), recognition (P<0.01).
Inlammatory component predicted rise in performance on recall (P<0.001), spatial ability (P<0.001), phonemic luency (P<0.01).
Nutritional component predicted rise in performance on recognition (P<0.01), phonemic luency (P<0.01).
There was no relationship between any health component and semantic luency.
2: Change in health factors between waves 1 and 2 associated with cognitive change between waves 1 and 2.
Glycaemic change predicted fall in performance on recognition (P<0.05), phonemic luency (P<0.05).
Lipid change predicted fall in spatial ability (P<0.01).
Inlammatory change predicted rise in performance on recall (P<0.001), recognition (P<0.01), spatial ability (P<0.001).
3: Change in health factors between waves 1 and 2 predicting cognitive change between waves 2 and 3.
Glycaemic change predicted fall in performance on recall (P<0.05), recognition (P<0.01).
Numerical results from each model are too numerous to include here.99
Not stated. Clustering: principal 
components analysis.
Cache County Study95 Four lifestyle classes identiied:
Unhealthy religious (11.5%)
Unhealthy non-religious (10.5%)
Healthy moderately religious (38.5%)
Healthy very religious (39.5%).
Compared with unhealthy religious: for dementia: unhealthy non-religious HR 0.54 (95% CI 0.31 to 0.93). Healthy moderately religious 
HR 0.56 (95% CI 0.38 to 0.84). Healthy very religious HR 0.58 (95% CI 0.40 to 0.84). Difference between the three classes above is 
non-signiicant. Reported as similar for Alzheimer’s disease (AD).
Age, sex, education, 
recruitment cohort and 
apolipoprotein (APOE) ε4 
status.
Clustering: latent class 
analysis to identify 
clusters.
Cardiovascular Risk 
Factors, Ageing and 
Dementia study101
20% had no baseline risk factors 41% had 1, 32% had 2, 7% had 3 baseline risk factors.
Compared with those with no baseline risk factors: for dementia:
one risk factor OR 1.37 (95% CI 0.44:4.27)
two risk factors OR 3.03 (95% CI 1.03:8.89)
three risk factors OR 6.21 (95% CI 1.94:19.92) n=1409 in the model. Relationship reported to be similar for AD.
Age, sex, education and 
follow-up time.
Unweighted risk factor 
score.
Coronary Artery Risk 
Development in Young 
Adults90
Prevalence of meeting the ideal metric (see deinition in previous column) decreased over the 25 year follow-up for all factors except 
non-smoking.
Higher scores of ideal health components at year 0 and the average across years 0, 7, 25 was associated with better performance on 
all three tests. Trend tests for cognitive performance and increasing score show signiicant results for all three cognitive tests for health 
component score at baseline and the average across the study.
Each additional ideal health component (average exposure) was associated with 1.32 more symbols on the Digit Symbol Substitution 
Test (95% CI 0.93 to 1.71), a 0.77 point lower interference score on the Stroop test (95% CI −1.03 to 0.45) and 0.12 more words recalled 
on the Rey Auditory Verbal Learning Test (95% CI 0.04 to 0.20).
Similar patterns were shown when the score cut point of ≥5 was used, that is, greater ideal health associated with better cognitive 
performance. Using the 0–14 score also resulted in a similar pattern of results. Sensitivity analysis using only those with complete data 
found similar results.
Age, sex, race (black/white), 
education, alcohol use and 
study centre.
Unweighted risk factor 
score.
Framingham Study96 Limited information provided in the article. Results for the scoring are provided in igure 1 of the article. The igure shows the highest 
cognitive scores in those with neither risk factor at baseline, the lowest scores in those with both risk factors and an intermediate level 
for those with one risk factor.
Results showed that a score of 1 or 2 was worse than a score of 0 for visual reproduction (P<0.002) and that a score of 2 was worse 
than a score of 0 or 1 for logical memory delayed recall (P<0.03).
Not stated Unweighted risk factor 
score.
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Study Result Covariates adjusted for Risk factor handling
Honolulu Asia Ageing 
Study88
Risk factor scores >1 SD above the mean were considered to be elevated; 24% had no elevated risk factors, 29% had 1 and 30% had 
2 or more.
Per one unit increase in summed z score adjusted for age and education, for dementia relative risk (RR) 1.06 (95% CI 1.02 to 1.10), AD 
RR 1.00 (95% 0.94 to 1.06), vascular dementia (VaD) RR 1.11 (1.04 to 1.18).
Compared with those with no elevated risk factors, for dementia
1 risk factor RR 0.9 (95% CI 0.62 to 1.32).
≥2 risk factors RR 1.56 (95% CI 1.12 to 2.18). Results were stronger for VaD.
Age and education Unweighted risk factor 
score.
Hoorn Study102 OR per point increase in risk factor score when only modiiable risk factors are included.
Information processing speed OR 1.22 (95% CI 0.99 to 1.51). Attention and executive function OR 1.26 (95% CI 1.04 to 1.54). 
Visuoconstruction OR 1.26 (95% CI 0.94 to 1.69).
Abstract reasoning OR 1.25 (95% CI 0.91 to 1.71).
Language OR 1.09 (95% CI 0.79 to 1.51).
Memory OR 0.84 (95% CI 0.68 to 1.03).
Z scores were adjusted on 
an individual basis for age, 
sex, IQ.
Weighted risk factor 
score, modiiable 
risk factor score was 
unweighted.
Intervention project on 
cerebrovascular disease 
and dementia in the 
district of Ebersberg104
For total score:
Score 9–12 HR 1 reference
Score 5–8 HR 0.98 (95% CI 0.72 to 1.33)
Score 0–4 HR 1.41 (95% CI 0.91 to 2.20)
For blood parameters alone:
Score 4–6 HR 1 reference
Score 3 HR 0.79 (95% CI 0.60 to 1.05)
Score 0–2 HR 0.95 (95% CI 0.72 to 1.25)
For health behaviours alone:
Score 4–6 HR 1 reference
Score 3 HR 0.98 (95% CI 0.73 to 1.31)
Score 0–2 HR 1.41 (95% CI 1.28 to 1.80)
Age, sex, education. Unweighted risk factor 
score.
Kaiser Permanente 
Medical Care Program93
Cardiovascular composite score for risk of dementia:
1 risk factor HR 1.27 (95% CI 1.02 to 1.58)
2 risk factors HR 1.59 (95% CI 1.28 to 1.98)
3 risk factors HR 2.19 (95% CI 1.63 to 2.93)
4 risk factors HR 2.61 (95% CI 1.22 to 5.60)
Age at midlife, age at 
case ascertainment, race, 
education, sex.
Unweighted risk factor 
score.
Kungsholmen project100 In over 6406 participant years of follow-up, there were 428 cases of dementia including 328 of AD. Overall, higher risk scores were 
associated with greater risk of incident dementia and AD. Overall vascular risk proile score
Dementia
0 Reference category
1 hour 1.11 (95% CI 0.79 to 1.58)
2 hours 1.65 (95% CI 1.12 to 2.42)
≥3 hours 2.48 (95% CI 1.46 to 4.20), p for trend <0.001
AD 0 reference category
1 hour 1.09 (95% CI 0.75 to 1.60)
2 hours 1.77 (95% CI 1.16 to 2.71)
≥3 hours 2.66 (95% CI 1.39 to 5.08), p for trend <0.001. Similar patterns, atherosclerotic risk proile, hypoperfusion risk proile.
Age, sex, education, baseline 
Mini-Mental State Examination 
(MMSE), BMI, antihypertensive 
use, coronary heart disease, 
APOE ε4 and survival status at 
follow-up.
Unweighted risk factor 
score.
Maastricht Ageing 
Study103
Risk score and incident dementia HR 1.19 (95% CI 1.08 to 1.32).
Risk score and incident cognitive decline HR 1.09 (95% CI 1.004 to 1.18). No association for linear mixed models.
Per point increase in risk score.
Age, sex and education. Weighted risk factor 
score.
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Study Result Covariates adjusted for Risk factor handling
Northern Manhattan 
Study91
Analysis excluding those with cognitive impairment at baseline. For change in
Executive function
2 vs 0–1 ideal health factors beta 0.076 (SE 0.116), p=0.513.
3 vs 0–1 ideal health factors beta 0.325 (SE 0.118), p=0.006.
4–7 vs 0–1 ideal health factors beta 0.091 (SE 0.133), p=0.497.
Semantic memory
2 vs 0–1 ideal health factors beta 0.220 (SE 0.111), p=0.047.
3 vs 0–1 ideal health factors beta 0.224 (SE 0.112), p=0.047.
4–7 vs 0–1 ideal health factors beta 0.222 (SE 0.128), p=0.082.
Episodic memory
2 vs 0–1 ideal health factors beta 0.268 (SE 0.115), p=0.020.
3 vs 0–1 ideal health factors beta 0.321 (SE 0.117), p=0.006.
4–7 vs 0–1 ideal health factors beta 0.314 (SE 0.132), p=0.018.
Processing speed
2 vs 0–1 ideal health factors beta 0.343 (SE 0.115), p=0.003.
3 vs 0–1 ideal health factors beta 0.392 (SE 0.117), p=0.001.
4–7 vs 0–1 ideal health factors beta 0.489 (SE 0.133), p<0.001.
Sex, race, medical insurance, 
time from baseline to 
neuropsychological data 
collection wave 1.
Unweighted risk factor 
score.
Personality and Total 
Health, Path through life 
study108
Overall higher PATHrisk score was associated with poorer cognitive function on all cognitive tests except reaction time. For 
relationships between PATHrisk and change in cognitive measures over time: the model including gender, time, PATHrisk*time and 
PATHrisk: found an association between PATHrisk*time and choice reaction time (beta −0.024 (SE 0.01)) The model including gender, 
time, education, time*PATHrisk and education*PATHrisk found no association between PATHrisk*time and cognitive score change. No 
relationship for individual risk factors. No relationship with global cognitive score.
Patterns of test completion. Unweighted risk factor 
score.
San Luis Valley Health 
ad Aging Study92
The Hispanic population had a worse risk factor proile than the white population.
General cognitive decline (MMSE) any 1 risk factor OR 1.09 (95% CI 0.70 to 1.71), any 2 risk factors OR 1.10 (95% CI 0.69 to 1.73), all 
3 risk factors OR 1.15 (95% CI 0.63 to 2.12).
Executive function decline (Behavioural Dyscontrol Scale) any 1 risk factor OR 1.07 (95% CI 0.59 to 1.92), any 2 risk factors OR 1.16 
(95% CI 0.64 to 2.11), all 3 risk factors OR 1.45 (95% CI 0.69 to 3.07).
Decade of age and education. 
Comparator not clear: 
assumed to be no risk factors.
Unweighted risk factor 
score.
Supplementation en 
vitamines et mineraux 
antioxydants study105
In the inal model, adjusting for other lifestyle risk factors plus those in next column, the only statistically signiicant relationship 
remaining was for alcohol comparing abstainers to users −1.26 (95% CI –2.11 to −0.40) such that abstainers had poorer verbal memory 
outcomes.
For score of unhealthy behaviours:
Compared with 0–1 unhealthy behaviours: for global composite cognitive performance at follow-up.
2 unhealthy behaviours mean difference in cognitive performance −1.57 (95% CI −2.98 to −0.16).
3 unhealthy behaviours mean difference in cognitive performance −1.69 (95% CI −3.06 to −0.33).
4 unhealthy behaviours mean difference in cognitive performance −1.75 (95% CI −3.20 to −0.30).
5–6 unhealthy behaviours mean difference in cognitive performance −2.10 (95% CI −3.82 to −0.37).
Similar patterns for score used as a continuous variable and for the same analyses with executive function and verbal memory 
outcomes. When looking at latent lifestyle factors, low fruit and vegetable consumption and low physical activity level appeared to be 
the main contributors to the unhealthy behaviours related to verbal memory. The unhealthy lifestyle latent factor was not associated 
with executive function.
Age, sex, education, time-
lag baseline to cognitive 
evaluation, occupational 
status, trial intervention 
group, energy intake, number 
of 24 hours records, BMI, 
depressive symptoms, 
baseline self-reported 
memory troubles, history of 
diabetes, hypertension and 
cardiovascular diseases.
Clustering: latent factors/
unweighted scoring.
Suwon Longitudinal 
Ageing Study109
Greater number of positive factors (non-smoking, vegetable consumption, physical activity and social activity) associated with greater 
change on MMSE.
Implied that change is associated with positive cognitive outcome.
1 protective factor beta 0.441 (SE 0.348).
2 protective factors beta 1.353 (SE 0.348).
3 protective factors beta 1.731 (SE 0.362).
When all factors entered into the same model only vegetable consumption and social activity remained statistically signiicant. Non-
smoking beta 0.393 (SE 0.253). Physical activity beta 0.310 (SE 0.195). Vegetable consumption beta 0.698 (SE 0.176). Social activity 
beta 0.626 (SE 0.187). No obvious pattern in particular combinations of protective factors. These analyses include the whole data set 
without exclusion of those with prevalent cognitive impairment. The authors report that they carried out sensitivity analyses excluding 
those with MMSE scores<19 and that the magnitude of the association diminished, although the direction of the association did not 
change.
Age, sex, marital status, 
education, lifetime occupation, 
diabetes, heart disease, 
hypertension and stroke.
Unweighted risk factor 
score.
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Study Result Covariates adjusted for Risk factor handling
Uppsala Longitudinal 
Study of Adult Men98
Risk factors at age 50, reference none
AD:
1: HR 0.9 (95% CI 0.6 to 1.5);
2: HR 1.2 (95% CI 0.8 to 2.0);
≥3: HR 0.5 (95% CI 0.2 to 1.2).
Vascular dementia:
1: HR 2.1 (95% CI 0.9 to 4.6);
2: HR 2.8 (95% CI 1.3 to 6.2);
≥3: HR 5.1 (95% CI 2.2 to 11.9).
AD, mixed or unspeciied dementia:
1: HR 1.3 (95% CI 0.9 to 1.9);
2: HR 1.5 (95% CI 1.0 to 2.2);
≥3: HR 1.4 (95% CI 0.9 to 1.4)
All dementia:
1: HR 1.4 (95% CI 1.0 to 1.9);
2: HR 1.7 (95% CI 1.2 to 2.3);
≥3: HR 2.1 (95% CI 1.5 to 3.2).
Risk factors at age 70 years—reference none
AD:
1: HR 1.0 (95% CI 0.8 to 2.3);
2: HR 2:1.0 (95% CI 0.6 to 1.9);
≥3: HR 0.4 (95% CI 0.1 to 1.3).
Vascular dementia:
1: HR 4.1 (95% CI 1.0 to 17.7);
2: HR 6.8 (95% CI 1.6 to 29.2);
≥3: HR 7.7 (95% CI 1.6 to 37.1).
AD, mixed or unspeciied dementia:
1: HR 1.6 (95% CI 1.1 to 2.5);
2: HR 1.4 (0.9 to 2.2);
≥3: HR 1.1 (0.5 to 2.1)
All dementia:
1: HR 1.8 (95% CI 1.2 to 2.6);
2: HR 1.7 (95% CI 1.1 to 2.6);
≥3: HR 1.7 (95% CI 1.0 to 2.9).
Age and education. Unweighted risk factor 
score.
Washington Heights 
cohort89
For probable and possible AD combined, diabetes, hypertension, heart disease and smoking were retained in multivariable analyses; 
26.0% had no risk factors, 37.8% had 1 risk factor, 25.3% had 2 risk factors, 9.4% had 3 risk factors and 0.9% had all risk factors.
When all four risk factors were included in the same model only diabetes (HR 2.0 (95% CI 1.4 to 2.9) and current smoking (HR 1.9 (95% 
CI 1.4 to 2.9) retained statistical signiicance. The corresponding results for heart disease and hypertension were HR 1.1 (95% CI 0.8 to 
1.5) and HR 1.1 (95% CI 0.9 to 1.5).
When number of risk factors was examined:
Compared with no risk factors for probable or possible AD:
1 risk factor HR 1.6 (95% CI 1.1 to 2.4);
2 risk factors HR 2.6 (95% CI 1.7 to 3.8);
3 or 4 risk factors HR 3.8 (95% CI 2.4 to 5.9).
Age and sex, a subsample 
additionally adjusted for 
education and APOE ε4 
showed similar results.
Unweighted risk factor 
score.
Washington Heights 
cohort97
Combined diet and physical activity. For the sample excluding those with a baseline clinical dementia rating scale score of 0.5 and with 
<2 years follow-up.
Low activity, low diet AD HR 1.00 reference;
Low activity, high diet HR 0.70 (95% CI 0.50 to 1.28);
High activity, low diet score HR 0.61 (95% CI 0.38 to 0.97);
High activity, high diet score HR 0.51 (95% CI 0.31 to 0.83);
Patterns of results were similar for the whole sample.
Cohort, age, sex, ethnicity, 
education, APOE ε4 status, 
caloric intake, BMI, smoking, 
depression, leisure activities, 
comorbidity index, time 
between irst dietary and irst 
physical activity assessment.
Weighted risk factor 
score.
Washington Heights 
cohort94
No real impact of vascular burden on cognitive change, risk factors were associated with a small attenuated decline in memory on 
black but not white or Hispanic participants.
For annual change in general cognitive performance; white −0.03 (95% CI −0.13 to 0.07), black 0.10 (95% CI 0.02 to 0.18), Hispanic 
0.06 (95% CI −0.02 to 0.14);
For annual change in executive function; white −0.03 (95% CI −0.13 to 0.07), black 0.02 (95% CI −0.06 to 0.10), Hispanic 0.0 (95% CI 
−0.06 to 0.10);
For annual change in memory; white 0.00 (95% CI −0.10 to 0.10), black 0.11 (95% CI 0.05 to 0.17), Hispanic 0.06 (95% CI 0.00 to 
0.12).
Age, sex, education, 
recruitment cohort and APOE 
ε4 status.
Unweighted risk factor 
score.
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Study Result Covariates adjusted for Risk factor handling
Whitehall II study106 Slopes from growth curve models estimating the combined effect of alcohol and smoking at baseline (1997–1999) on cognitive decline 
(2002–2004 to 2007–2009). Being a heavy drinker and current smoker was associated with faster decline.
Non-drinker and:
Never smoker −0.40 (95% CI −0.46 to −0.34);
Ex-smoker −0.38 (95% CI −0.46 to −0.30);
Current smoker −0.50 (95% CI −0.65 to −0.35).
Moderate drinker (within UK recommended limits) and:
Never smoker −0.42 (95% CI −0.45 to −0.39);
Ex-smoker −0.42 (95% CI −0.45 to −0.38);
Current smoker −0.37 (95% CI −0.44 to −0.29).
Heavy drinker (>UK recommended limits) and:
Never smoker −0.42 (95% CI −0.47 to −0.37);
Ex-smoker −0.45 (95% CI −0.49 to −0.41);
Current smoker −0.57 (95% CI −0.67 to −0.48).
Sensitivity analysis to exclude those with MMSE<24 at follow-up showed similar results.
Age, gender, prevalent chronic 
disease and education
Used categories to 
examine additive impact.
Whitehall II study107 At baseline: 8.4% had no unhealthy behaviours. Other data not given. Examining the relationship between unhealthy behaviours at 
phase I and poor executive function at phase VII:
Compared with no unhealthy behaviours:
Those with:
1 unhealthy behaviour OR 1.34 (95% CI 0.96 to 1.87);
2 unhealthy behaviours OR 1.38 (95% CI 0.99 to 1.93);
3–4 unhealthy behaviours OR 1.84 (95% CI 1.27 to 2.65).
Examining the relationship between unhealthy behaviours at phase I and poor executive function at phase V: compared with no 
unhealthy behaviours:
Those with:
1 unhealthy behaviour OR 1.38 (95% CI 1.09 to 1.74);
2 unhealthy behaviours OR 1.83 (95% CI 1.43 to 2.33);
3–4 unhealthy behaviours OR 2.38 (95% CI 1.76 to 3.22).
Similar pattern for unhealthy behaviour at phase I and memory.
No clear patterns for different combinations of health behaviours.
Cumulative score of summed health behaviours over time. Compared with those scoring
0–2: for executive function:
3–5 OR 1.58 (95% CI 1.27 to 1.98);
6–8 OR 2.52 (95% CI 1.96 to 3.24);
9–12 OR 2.87 (95% CI 1.90 to 4.32).
Similar pattern for memory.
Age, sex and socioeconomic 
position at the corresponding 
stage of assessment.
Unweighted risk factor 
score.
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supplementary text 2). For AD,89 98 100 fixed effect pooled 
risk ratios for one risk factor were 1.2 (95% CI 0.9 to 1.5), 
for two risk factors 1.8 (95% CI 1.4 to 2.3) and for three 
or more risk factors 1.2 (95% CI 0.2 to 6.1). The results 
for the random effects model were 1.2 (95% CI 0.9 to 
1.6) for one risk factor, 1.8 (95% CI 1.2 to 2.8) for two 
risk factors and 1.5 (95% CI 0.9 to 2.5) for three or more 
risk factors. For AD, the heterogeneity was high and the 
number of constituent studies was low, restricting anal-
ysis of publication bias (online supplementary text 2). 
Visual examination of the plotted results per incremental 
risk factor for the studies included in the meta-analysis 
showed no clear pattern by study baseline age, population 
sex distribution, length of follow-up or study covariates; 
however, the small numbers precluded meta-regression 
or other formal statistical testing.
study quality
Of the 22 articles, 14 were assessed as having an overall 
medium risk of bias88 92 93 95 96 98 99 101 102 104–107 109; 7 as having 
a low risk89 90 94 97 100 103 108 and 1 as having high risk.91 Risk 
of bias was assessed with regard to recruitment, exposure 
(eg, assessments of risk factor exposure), outcome (eg, 
assessment tools, use of blinded assessors) and follow-up 
(eg, attrition, length of follow-up) (online supplemen-
tary table 2). Several studies analysed population-based 
cohorts,89 92–97 99–103 108 109 some specifying that their anal-
yses were based on selective populations.90 91 95 96 98 101 102 105 
Two studies were specifically designed to recruit selective 
populations; the Honolulu Asia Ageing Study which only 
included Japanese American men living in Honolulu88 
and the Whitehall study which recruited exclusively 
from a civil servant population.106 107 Two further studies 
Figure 2 Forest plots showing dose response for exposure to increasing numbers of risk factors and risk of incident dementia 
for individual studies Follow-up 27 years for the Honolulu Asia Ageing Study (HAAS) cohort, 20 years for the Uppsala cohort, 
~5 years for the Kungsholmen cohort, 26.7 for the Kaiser Permanente cohort and 21 years for the Cardiovascular Risk factors 
Ageing and Dementia (CAIDE) cohort. RF, risk factor; RR, relative risk.
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recruited from previously existing healthcare provider or 
insurance databases.93 104 All studies used recognised and 
standard measures to characterise baseline risk factors, 
although variation in the evidence base, current guide-
lines and recommendations at the time of study data 
collection and analysis inevitably resulted in diverse risk 
factor definitions.
Regarding outcome measurement and length 
of follow-up, two studies reported follow-up likely 
to be <5 years, putting them at risk of reverse 
causality92 109; however, five studies reported long (ie, 
>20 years) follow-up88 90 93 96 101 and three of these reported 
incident dementia outcomes.88 93 101 Two studies used 
dementia outcomes taken from medical databases,93 104 
which may have underestimated the number of cases, 
but all other studies used standard diagnostic criteria 
or standard neuropsychological tests. The majority of 
studies reported on incident dementia or on change 
in cognitive function assessed using neuropsycholog-
ical tests; however, five studies reported cognitive func-
tion only at follow-up, potentially including prevalent, 
rather than incident, cases of poor function.90 96 102 105 107 
The majority of studies adjusted for age, sex and educa-
tion, although some carried out further adjustment for 
wider covariates. Finally, details of how researchers had 
accounted for missing data and attrition were not consis-
tently reported with information provided in around half 
the articles.90 92 94 96 97 99 100 105–108
DIsCussIOn
This systematic review of the evidence base relating 
to intraindividual co-occurring modifiable risk factors 
for dementia and cognitive decline found a clear rela-
tionship between the presence of/exposure to greater 
numbers of baseline risk factors and an increased 
risk of later cognitive decline or incident dementia. 
The converse was also seen in identifying a relation-
ship between greater numbers of protective factors 
or healthy behaviours and a reduced risk of cognitive 
decline or dementia.
Studies reporting risk ratios for all-cause dementia 
per incremental risk factor consistently demonstrated a 
clear dose-response relationship. When combined in a 
meta-analysis, a 20% increase in dementia risk with the 
presence of one risk factor (combined risk ratio 1.2 (95% 
CI 1.0 to 1.4)) was observed rising to 65% for two risk 
factors (1.7 (95% CI 1.4 to 1.9)). Presence of three risk 
factors doubled the risk of dementia with a combined 
risk ratio of 2.2 (95% CI 1.8 to 2.7). Fewer studies and 
incident cases were identified for a similar meta-analysis 
of AD with the dose response only being evident for the 
presence of one and two risk factors.
Although data relating to summed risk or protec-
tive factors showed clear relationships with cognitive 
outcomes, limited data were available on clustering of 
specific risk factors and subsequent cognitive outcomes. 
Only three studies used statistical clustering techniques 
and the methods are too diverse and the results too varied 
to allow conclusions to be drawn.
To our knowledge, this is the first review to examine 
the impact of intraindividual co-occurring modifiable 
risk factors and risk of dementia and cognitive decline. 
As such, comparison to prior similar work in this area is 
difficult, however, scoring systems involving the sum, or 
weighted sum of individual risk factors, including both 
modifiable and non-modifiable risk factors, have been 
widely used in other areas such as cancer,111 all-cause 
mortality112 and, especially, cardiovascular disease.113 A 
recent systematic review reported on 363 such cardio-
vascular disease risk scores or models114 and several 
such cardiovascular and other scores have also been 
used to predict dementia outcomes.46 Our findings are 
congruent with such scoring systems and are biologically 
plausible with higher numbers of vascular risk factors in 
midlife associated with elevated amyloid deposition in 
addition to vascular damage.115 What our findings add 
is the first quantifiable estimation of the impact of risk 
factor accrual. What we were unable to add is evidence 
related to particular risk factor clusters. In fact, data on 
the impact of modifiable risk factor clusters are rare, 
although recent work on all-cause mortality found that 
combinations of specific risk factors, for example, phys-
ical inactivity, prolonged sitting and short or long sleep 
duration are associated with higher levels of mortality 
risk.112
limitations
Our review is inevitably limited by its exclusive depen-
dence on published results. This meant that we were 
unable to: i) statistically evaluate trends within individual 
studies, ii) evaluate the impact of additional covariates, 
iii) evaluate the impact of particular population char-
acteristics or iv) the potential for particular risk factors 
having a greater or lesser impact. We were also unable to 
explore the relationship between specific risk factor clus-
ters or between greater risk factor burden and cognition 
beyond that assessed by the included studies and there 
was considerable variability in the modifiable risk factors 
addressed in each study (online supplementary table 1), 
thus limiting the opportunity for unpicking individual 
factor impact. A further limitation relates to restricting 
inclusion to known and widely accepted modifiable 
risk factors. While this makes findings more amenable 
to public health dissemination, it may omit important 
unknown or emerging modifiable risk factors, such as air 
pollution.116 117 Furthermore, despite not being amenable 
to intervention and therefore not the focus of this review 
non-modifiable risk factors also undoubtedly play a role. 
The use of a binary classification for risk or protective 
factors, while clinically practical, may also have resulted 
in a loss of subtlety, particularly since definitions of risk 
differed across studies. Risk factors are also associated with 
participant attrition and few studies took this into account 
in modelling. Furthermore, few papers considered poten-
tial treatment effects. Finally, although we concentrated 
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on adulthood, emerging evidence is suggesting a poten-
tial role for accrual of exposure to vascular risk factors in 
childhood and poorer cognition in midlife.118
Inevitably results drawn from longitudinal cohort 
studies are subject to bias, and, as is often the case in 
systematic reviews, the length of follow-up, assessment 
of outcomes and use of covariates varied. The strength 
of the evidence also needs to take into account the two 
studies contributing more than one analysis. Further-
more, generalisability may also be limited since the study 
populations were drawn exclusively from high-income 
countries and, as such, may reflect a more homogeneous, 
and potentially more medicated or treated, population 
than those in low-income and middle-income countries 
where risk factor prevalence, recognition and treatment 
rates may differ.
A further consideration in the existing studies is the way 
in which age is considered beyond its role as a covariate. 
Age is the most important risk factor for dementia well 
into the tenth decade119 and although not a modifiable 
risk factor, it is a source of important and thus far poorly 
understood heterogeneity in risk for many diseases of 
older age, including dementia.120 The role of age, or 
time, in evaluating duration, as well as presence, of risk 
factors may be key and so far few studies have exam-
ined this.121–126 Ageing is associated with widespread 
processes of deficit accumulation: beginning at molec-
ular and subcellular levels,127 and scaling up128 to become 
detectable as biomarkers129; then by routine laboratory 
methods130 and then clinically.130 In general, the studies 
of deficit accumulation, in both general samples and in 
special groups such as people with HIV-AIDS131 or intel-
lectual disabilities,132 show that any risk factors which are 
age-related and adverse (eg, associated with mortality) 
will increase the risk of cognitive decline. This some-
times raises the objection that combining deficits in this 
manner makes it hard to know which ones are important. 
The counterargument is that this is not how age-related 
disease works. Often, many of the factors that in the aggre-
gate are strongly associated with dementia (and which 
notably reduce the explanatory value of age) are not 
themselves significantly associated with cognitive decline 
when considered one at a time.124–126 The better remedy 
is to consider which other factors might mitigate (eg, 
health protective behaviours) or exacerbate (eg, social 
vulnerability) the adverse effects of such deficits on cogni-
tion.125 As this approach is comparatively new—at least in 
its application to cognitive decline and dementia—there 
is as yet little to review. Given, however, the recent report 
from two prospective, community-based autopsy studies, 
showing that in one-quarter of patients with a history of 
delirium, accelerated cognitive decline was not related 
to classical neuropathology suggests that there is much 
to learn about how late-life dementia is related to overall 
health.133 Such observations encourage widening the 
scope of investigative approaches.
Notwithstanding these limitations, this is the most 
comprehensive and, to our knowledge, the first synthesis 
of evidence on the impact of co-occurring risk factors 
for dementia. It presents an evidence base that is largely 
consistent and may imply a potentially very simple rela-
tionship such that the higher the number of risk factors 
to which a person is exposed the greater their risk. The 
potential for a causal relationship is supported by the 
consistent finding across studies, the use of popula-
tion-based samples although with some inevitable risk of 
bias, the longitudinal nature of the data, the suggestion 
of a dose-response relationship and the strength of the 
association between the summed risk factors. Further 
research is required to determine whether particular 
combinations of risk factors have greater impacts on 
cognitive function than others, which clinical thresh-
olds should be used to classify risk or whether relation-
ships differ in different population groups, for example, 
at extreme age. More understanding is also needed for 
the relationship between modifiable and non-modifiable 
factors and risk factor combinations, not least to stratify 
population subgroups and identify those at highest risk. 
Currently, the best course of action for both individuals 
and health organisations would be to seek to keep modi-
fiable risk factor exposure to a minimum and to prevent 
exposure to further risk factors. The current findings 
support the use of risk indices for screening those at high 
risk of dementia and indicated for intervention.
COnClusIOns
The evidence relating to the impact of co-occurring, 
within individual, risk factors and the risk of cognitive 
decline or dementia is highly consistent. It demonstrates 
that greater numbers of risk factors are associated with 
worse cognitive outcomes and greater numbers of protec-
tive factors with better cognitive outcomes. We provide 
quantitative evidence of a dose response such that one 
risk factor is associated with an 20% increase in risk of 
incident dementia, two risk factors with an 65% increased 
risk and three or more with a doubling of risk. Our results 
support the need for clinicians, public health organ-
isations and individuals to keep risk factor exposure to 
a minimum and even where risk factors are present to 
prevent further accrual.
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